NCT02015507View on ClinicalTrials.gov

An Open-Label, Phase 1 Study in Healthy Adult Subjects to Examine the Effects of Multiple-Dose Ciprofloxacin on Ivacaftor and VX-661 in Combination With Ivacaftor

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Cystic Fibrosis
Interventions
DRUG

ivacaftor

DRUG

VX-661

DRUG

ciprofloxacin

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY

NCT02015507 - An Open-Label, Phase 1 Study in Healthy Adult Subjects to Examine the Effects of Multiple-Dose Ciprofloxacin on Ivacaftor and VX-661 in Combination With Ivacaftor | Biotech Hunter | Biotech Hunter